Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases

Acta Neuropathologica

Volumn 91, Issue 6, 1996, Pages 566-572

  Leveugle, B ^a,e   Faucheux, B A ^b   Bouras, C ^a,c   Nillesse, N ^d   Spik, G ^d   Hirsch, E C ^b   Agid, Y ^b   Hof, P R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ferritin; Free radicals; Neurodegenerative disorders; Oxidative stress; Transferrins

Indexed keywords

LACTOFERRIN;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NERVE CELL; NERVE CELL DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

AGED; AGED, 80 AND OVER; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IRON-BINDING PROTEINS; LACTOFERRIN; MALE; MESENCEPHALON; MIDDLE AGED; PARKINSON DISEASE; TRANSFERRIN-BINDING PROTEINS;

EID: 0029997918     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050468     Document Type: Article

References (59)

1. Agid Y, Ruberg M, Agid F, Hirsch E, Raisman-Vozari R, Vyas S, Faucheux B, Michel P, Kastner A, Blanchard V, Damier P, Villares J, Zhang P (1993) Are dopaminergic neurons selectively vulnerable to Parkinson's disease? Adv Neurol 60: 148-164
2. Aisen P, Listowsky I (1981) Iron transport and storage. Annu Rev Biochem 49: 357-398
3. Ambruso DR, Johnston RB (1981) Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. J Clin Invest 67: 352-360
4. Baggiolini M, De Duve C, Masson PL, Heremans JF (1970) Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med 131: 559-570
5. Bannister JV, Bannister WH, Hill HAO, Thornalley PJ (1982) Enhanced production of hydroxyl radicals by the xanthine-xanthine oxidase reaction in the presence of lactoferrin. Biochim Biophys Acta 715: 116-121
6. Birgens HS (1985) Lactoferrin in plasma measured by an ELISA technique: evidence that plasma lactoferrin is an indicator of neutrophil turnover and bone marrow activity in acute leukaemia. Scand J Haematol 34: 326-331
7. Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 172: 151-154
8. Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, Harford JB (1988) Iron responsive elements regulatory RNA sequences that control mRNA levels and translation. Science 240: 924-928
9. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1990) Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. J Neurosci Res 27: 595-611
10. Connor JR, Menzies SL, St Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 31: 75-83
11. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ (1992) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 31: 327-335
12. Davidson LA, Lonnerdal B (1989) Fe-saturation and proteolysis of human lactoferrin: effect on brush-border receptor mediated uptake of Fe and Mn. Am J Physiol 257: G930-G934
13. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52: 1830-1836
14. Dexter DT, Carayon A, Vidailhert M, Rubert M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD (1990) Decreased ferritin levels in brain in Parkinson's disease. J Neurochem 55: 16-20
15. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114: 1953-1975
16. Enochs WS, Sarna T, Zecca L, Riley PA, Swartz HM (1994) The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J Neural Transm Park Dis Dement Sect 7: 83-100
17. 125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys. Brain Res 691: 115-124
18. 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease. J Neurochem 60: 2338-2341
19. Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y, Hirsch EC (1995) Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci USA 92: 9603-9607
20. Fearnley J, Lees A (1994) Pathology of Parkinson's disease. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 545-554
21. Gerber MR, Connor JR (1989) Do oligodendrocytes mediate iron regulation in the human brain? Ann Neurol 26: 95-98
22. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63: 793-806
23. Good PF, Olanow CW, Perl DP (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 593: 343-346
24. Guntern R, Bouras C, Hof PR, Vallet PG (1992) An improved thioflavine-S method for neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 48: 8-10
25. Gutteridge JMC (1992) Iron and oxygen radicals in brain. Ann Neurol 32 [Suppl]: S16-S21
26. Hill JM, Ruff MR, Weber RJ, Pert CB (1985) Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci USA 82: 4553-4557
27. Hirsch EC (1992) Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann Neurol 32 [Suppl]: S88-S93
28. Hirsch EC, Graybiel AM, Agid Y (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334: 345-348
29. Hirsch EC, Brandel J, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminium inscrease in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56: 446-451
30. Hu WL, Mazurier J, Sawatzki G, Montreuil J, Spik G (1988) Lactotransferrin receptor of mouse small intestinal brush border. Biochem J 249: 435-441
31. Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MBH (1990) Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect 2: 327-340
32. Jellinger K, Kienzl E, Rumpelmaier G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MBH (1992) Iron-melanin complex in substantia nigra of Parkinsonian brains: an x-ray microanalysis. J Neurochem 59: 1168-1171
33. Kawamata T, Tooyama I, Yamada T, Walker DG, McGeer PL (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brains. Am J Pathol 142: 1574-1585
34. Klebannof SJ, Waltersdorph AM (1990) Prooxidant activity of transferrin and lactoferrin. J Exp Med 172: 1293-1303
35. Leveugle B, Spik G, Perl DP, Bouras C, Fillit HM, Hof PR (1994) The iron binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res 650: 20-31
36. Lillie RD (1957) Trichoxanthin, the yellow granular pigment of guinea pig hair follicles and hairs. J Histochem Cytochem 5: 346-353
37. Ma SY, Röyttä M, Rinne JO, Collan Y, Rinne UK (1995) Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease. Neuropathol Appl Neurobiol 21: 341-343
38. Mann VM, Cooper JM, Daniel SE, Srai K, Jenner P, Marsden CD, Schapira AHV (1994) Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 36: 876-881
39. Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ (1991) Distribution and number of transferrin receptors in Parkinson's disease and in MPTP treated mice. Exp Neurol 114: 73-81
40. Mash DC, Sanchez-Ramos J, Weiner WJ (1993) Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice. Adv Neurol 60: 133-139
41. Mazurier J, Spik G (1980) Comparative study of the iron-binding properties of human transferrins. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim Biophys Acta 629: 399-408
42. Morris CM, Edwardson JA (1994) Iron histochemistry of the substantia nigra. Neurodegeneration 3: 277-282
43. Morris CM, Candy JM, Bloxham CA, Edwardson JA (1992) Immunocytochemical localisation of transferrin in the human brain. Acta Anat (Basel) 143: 14-18
44. Morris CM, Candy JM, Omar S, Bloxham CA, Edwardson JA (1994) Transferrin receptors in the parkinsonian midbrain. Neuropathol Appl Neurobiol 20: 468-472
45. Olanow CW (1990) Oxidation reactions in Parkinson's disease. Neurology 40: 32-37
46. Olanow CW, Drayer B (1987) Brain iron: MRI studies in Parkinson's syndrome. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson's disease. Macmillan Healthcare Information, Florham Park, pp 135-143
47. Osmand AP, Switzer III RC (1991) Differential distribution of luctoferrin and Alz-50 immunoreactivities in neuritic plaques and neurofibrillary tangles in Alzheimer's disease. In: Iqbal K, McLachlan RC, Winblad B, Wisniewski HM (eds) Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies. Wiley, New York, pp 219-227
48. Perry G, Stewart D, Friedman R, Manetto V, Autillo-Gambetti L, Gambetti P (1987) Filament's of Pick's bodies contain altered cytoskeletal elements. Am J Pathol 127: 559-568
49. Rebeck GW, Harr SD, Strickland DK, Hyman BT (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha-macroglobulin receptor/low density lipoprotein receptor-related protein. Ann Neurol 37: 211-217
50. Riederer P, Sofie E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J Neurochem 52: 515-520.
51. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MBH (1988) Increased iron (III) and total iron content in post mortem substantia nigra of Parkinsonian brain. J Neural Transm 74: 199-205
52. Srivastava CH, Rado TA, Bauerle D, Broxmeyer HE (1991) Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor alpha. J Immunol 146: 1014-1019
53. Theil EC (1994) Iron regulatory elements: a family of mRNA non-coding sequences. Bioehem J 304: 1-11
54. Trojanowski JQ, Schmidt ML, Shin RW, Bramblett GT, Rao D, Lee VMY (1993) Altered Tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol 3: 45-54
55. Uchihara T, Kondo H, Ikeda K, Kosaka K (1995) Alzheimer-type pathology in melanin-bleached sections of substantia nigra. J Neurol 242: 485-489
56. Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol 83: 170-178
57. Van Snick JL, Masson PL, Heremans JF (1974) The involvement of lactoferrin in the hyposideremia and acute inflammation. J Exp Med 140: 1068-1084
58. Yamada Y, Amagasaki T, Jacobsen DW, Green R (1987) Lactoferrin binding by leukemia cell lines. Blood 70: 264-270
59. Youdim MBH, Ben-Shachar D, Riederer P (1994) The enigma of neuromelanin in Parkinson's disease substantia nigra. J Neural Transm 43: 113-122